DRUG · Mapped RxNorm record
Sandostatin
Normalized identity: SandostatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Stress, Diurnal Cortisol, and Breast Cancer Survival
NCT00226967
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStress, Diurnal Cortisol, and Breast Cancer Survival
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
SandostatinDRUG · verified · RxNorm: Sandostatin
Sponsors & collaborators
Stanford Universitylead sponsor
National Institute on Aging (NIA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00226967 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.